Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 12/12/2014 11:01:59 PM
Post# of 30066
Posted By: nelito
Risk,

"We have put the necessary infrastructure in place to have the first patient dosed in our Phase 2b trial for Eltoprazine by the end of 2014, or very early 2015 (in or around the JP Morgan Healthcare Conference) "

I know he definitely pointed to the Conference as a staging point for some developments. I haven't found it all yet, but the aforementioned was part of it.

Manolo













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site